{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:45:22Z","timestamp":1793684722543,"version":"4.5.1"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Subjects with immune-mediated inflammatory diseases (IMID), such as rheumatoid arthritis (RA), have an intrinsic higher probability to develop active-tuberculosis (TB) compared to the general population. The risk ranges from 2.0 to 8.9 in RA patients not receiving therapies. According to the WHO, the RA prevalence varies between 0.3% and 1% and is more common in women and in developed countries. Therefore, the identification and treatment of TB infection (TBI) in this fragile population is important to propose the TB preventive therapy. We aimed to study the M. tuberculosis (Mtb) specific T-cell response to find immune biomarkers of Mtb burden or Mtb clearance in patients with different TB status and different risk to develop active-TB disease. We enrolled TBI subjects as example of Mtb-containment, the active-TB as example of a replicating Mtb status, and the TBI-IMID as fragile population. To study the Mtb-specific response in a condition of possible Mtb sterilization, we longitudinally enrolled TBI subjects and active-TB patients before and after TB therapy. Peripheral blood mononuclear cells were stimulated overnight with Mtb peptides contained in TB1- and TB2-tubes of the Quantiferon-Plus kit. Then, we characterized by cytometry the Mtb-specific CD4 and CD8 T cells. In TBI-IMID, the TB therapy did not affect the ability of CD4 T cells to produce interferon-\u03b3, tumor necrosis factor-\u03b1, and interleukin-2, their functional status, and their phenotype. The TB therapy determined a contraction of the triple functional CD4 T cells of the TBI subjects and active-TB patients. The CD45RA<jats:sup>-<\/jats:sup> CD27<jats:sup>+<\/jats:sup> T cells stood out as a main subset of the Mtb-specific response in all groups. Before the TB-preventive therapy, the TBI subjects had higher proportion of Mtb-specific CD45RA<jats:sup>-<\/jats:sup>CD27<jats:sup>+<\/jats:sup>CD4<jats:sup>+<\/jats:sup> T cells and the active-TB subjects had higher proportion of Mtb-specific CD45RA<jats:sup>-<\/jats:sup>CD27<jats:sup>-<\/jats:sup>CD4<jats:sup>+<\/jats:sup> T cells compared to other groups. The TBI-IMID patients showed a phenotype similar to TBI, suggesting that the type of IMID and the IMID therapy did not affect the activation status of Mtb-specific CD4 T cells. Future studies on a larger and better-stratified TBI-IMID population will help to understand the change of the Mtb-specific immune response over time and to identify possible immune biomarkers of Mtb-containment or active replication.<\/jats:p>","DOI":"10.3389\/fimmu.2021.716857","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T04:28:52Z","timestamp":1628569732000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Elisa","family":"Petruccioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Petrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Chiacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Farroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Cuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Navarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Massafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Lo Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Guggino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Caccamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Cantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"B1","unstructured":"TB REPORT 20202020"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","article-title":"The Global Burden of Latent Tuberculosis Infection: A Re-Estimation Using Mathematical Modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PloS Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13272","article-title":"Update on Tuberculosis Biomarkers: From Correlates of Risk, to Correlates of Active Disease and of Cure From Disease","volume":"23","author":"Goletti","year":"2018","journal-title":"Respirology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2738","article-title":"Revisiting the Timetable of Tuberculosis","volume":"362","author":"Behr","year":"2018","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01012-2016","article-title":"Correlates of Tuberculosis Risk: Predictive Biomarkers for Progression to Active Tuberculosis","volume":"48","author":"Petruccioli","year":"2016","journal-title":"Eur Respir J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.017","article-title":"Risk of Active Tuberculosis in the Five Years Following Infection . . 15%","volume":"149","author":"Trauer","year":"2016","journal-title":"Chest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.011","article-title":"Guidance for the Management of Patients With Latent Tuberculosis Infection Requiring Biologic Therapy in Rheumatology and Dermatology Clinical Practice","volume":"14","author":"Cantini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8909834","article-title":"Risk of Tuberculosis Reactivation in Patients With Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics","volume":"2017","author":"Cantini","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3899\/jrheum.140103","article-title":"Tuberculosis Risk in Patients Treated With Non-Anti-Tumor Necrosis Factor-\u03b1 (TNF-\u03b1) Targeted Biologics and Recently Licensed TNF-\u03b1 Inhibitors: Data From Clinical Trials and National Registries","volume":"91","author":"Cantini","year":"2014","journal-title":"J Rheumatol Suppl"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1483238","article-title":"Preventive Therapy for Tuberculosis in Rheumatological Patients Undergoing Therapy With Biological Drugs","volume":"16","author":"Goletti","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1612872","article-title":"Risk of Tuberculosis Reactivation Associated With Traditional Disease Modifying Anti-Rheumatic Drugs and Non-Anti-Tumor Necrosis Factor Biologics in Patients With Rheumatic Disorders and Suggestion for Clinical Practice","volume":"18","author":"Cantini","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/annrheumdis-2020-218398","article-title":"Points to Consider for the Treatment of Immune-Mediated Inflammatory Diseases With Janus Kinase Inhibitors: A Consensus Statement","volume":"80","author":"Nash","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1774550","article-title":"Systematic Review on Tuberculosis Risk in Patients With Rheumatoid Arthritis Receiving Inhibitors of Janus Kinases","volume":"19","author":"Cantini","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1086\/505430","article-title":"Tumor-Necrosis-Factor Blockers: Differential Effects on Mycobacterial Immunity","volume":"194","author":"Saliu","year":"2006","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003417","article-title":"Accuracy of Immunodiagnostic Tests for Active Tuberculosis Using Single and Combined Results: A Multicenter TBNET-Study","volume":"3","author":"Goletti","year":"2008","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01391.x","article-title":"Accuracy of an Immune Diagnostic Assay Based on RD1 Selected Epitopes for Active Tuberculosis in a Clinical Setting: A Pilot Study","volume":"12","author":"Goletti","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.12.031","article-title":"Latent Tuberculosis Infection Screening in Persons Newly-Diagnosed With HIV Infection in Italy: A Multicentre Study Promoted by the Italian Society of Infectious and Tropical Diseases","volume":"92","author":"Goletti","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1800946","DOI":"10.1183\/13993003.00946-2018","article-title":"An Evaluation Framework for New Tests That Predict Progression From Tuberculosis Infection to Clinical Disease","volume":"52","author":"Kik","year":"2018","journal-title":"Eur Respir J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic Value of Interferon-\u03b3 Release Assays and Tuberculin Skin Test in Predicting the Development of Active Tuberculosis (UK PREDICT TB): A Prospective Cohort Study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","article-title":"Effect of Immunosuppressive Therapy on Interferon \u03b3 Release Assay for Latent Tuberculosis Screening in Patients With Autoimmune Diseases: A Systematic Review and Meta-Analysis","volume":"71","author":"Wong","year":"2016","journal-title":"Thorax"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.09.012","article-title":"Lymphocyte Subset Analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for Latent Tuberculosis Infection in Rheumatoid Arthritis","volume":"24","author":"Igari","year":"2018","journal-title":"J Infect Chemother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium Tuberculosis Infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.imlet.2018.04.001","article-title":"Impact of Antiretroviral and Tuberculosis Therapies on CD4(+) and CD8(+) HIV\/M. Tuberculosis-Specific T-Cell in Co-Infected Subjects","volume":"198","author":"Chiacchio","year":"2018","journal-title":"Immunol Lett"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir951","article-title":"Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium Tuberculosis","volume":"54","author":"Andrews","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional Capacity of Mycobacterium Tuberculosis-Specific T Cell Responses in Humans Is Associated With Mycobacterial Load","volume":"187","author":"Day","year":"2011","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1465-9921-8-5","article-title":"Isoniazid Prophylaxis Differently Modulates T-Cell Responses to RD1-Epitopes in Contacts Recently Exposed to Mycobacterium Tuberculosis: A Pilot Study","volume":"8","author":"Goletti","year":"2007","journal-title":"Respir Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15626","DOI":"10.1038\/s41598-018-33825-w","article-title":"Effect of Therapy on Quantiferon-Plus Response in Patients With Active and Latent Tuberculosis Infection","volume":"8","author":"Petruccioli","year":"2018","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jinf.2019.04.010","article-title":"Characterization of QuantiFERON-TB-Plus Results in Latent Tuberculosis Infected Patients With or Without Immune-Mediated Inflammatory Diseases","volume":"79","author":"Chiacchio","year":"2019","journal-title":"J Infect"},{"key":"B29","doi-asserted-by":"publisher","first-page":"103233","DOI":"10.1016\/j.ebiom.2021.103233","article-title":"Immune Profiling of Mycobacterium Tuberculosis-Specific T Cells in Recent and Remote Infection","volume":"64","author":"Mpande","year":"2021","journal-title":"EBioMedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.chom.2017.05.012","article-title":"Antigen Availability Shapes T Cell Differentiation and Function During Tuberculosis","volume":"21","author":"Moguche","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.02.004","article-title":"Ifn\u03b3\/Tnf\u03b1 Specific-Cells and Effector Memory Phenotype Associate With Active Tuberculosis","volume":"66","author":"Petruccioli","year":"2013","journal-title":"J Infect"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium Tuberculosis","volume":"5","author":"Prezzemolo","year":"2014","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0231-6","article-title":"Host Resistance to Pulmonary Mycobacterium Tuberculosis Infection Requires CD153 Expression","volume":"3","author":"Sallin","year":"2018","journal-title":"Nat Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-020-0322-6","article-title":"Mycobacterium Tuberculosis-Specific CD4 T Cells Expressing CD153 Inversely Associate With Bacterial Load and Disease Severity in Human Tuberculosis","volume":"14","author":"Du Bruyn","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI77990","article-title":"Biomarkers on Patient T Cells Diagnose Active Tuberculosis and Monitor Treatment Response","volume":"125","author":"Adekambi","year":"2015","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1176","article-title":"Disease Extent and Anti-Tubercular Treatment Response Correlates With Mycobacterium Tuberculosis-Specific CD4 T-Cell Phenotype Regardless of HIV-1 Status","volume":"9","author":"Riou","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1800153","DOI":"10.1183\/13993003.00153-2018","article-title":"T-Cell Biomarkers for Diagnosis of Tuberculosis: Candidate Evaluation by a Simple Whole Blood Assay for Clinical Translation","volume":"51","author":"Musvosvi","year":"2018","journal-title":"Eur Respir J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.06.007","article-title":"Use of Several Immunological Markers to Model the Probability of Active Tuberculosis","volume":"86","author":"Petruccioli","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043733","article-title":"Mtb-Specific CD27low CD4 T Cells as Markers of Lung Tissue Destruction During Pulmonary Tuberculosis in Humans","volume":"7","author":"Nikitina","year":"2012","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.07.009","article-title":"Assessment of CD27 Expression as a Tool for Active and Latent Tuberculosis Diagnosis","volume":"71","author":"Petruccioli","year":"2015","journal-title":"J Infect"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70884-9","article-title":"Assessment of the Novel T-Cell Activation Marker-Tuberculosis Assay for Diagnosis of Active Tuberculosis in Children: A Prospective Proof-of-Concept Study","volume":"14","author":"Portevin","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00972","article-title":"Cell Differentiation Degree as a Factor Determining the Role for Different T-Helper Populations in Tuberculosis Protection","volume":"10","author":"Lyadova","year":"2019","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/eji.201747184","article-title":"Detailed Characterization of Human Mycobacterium Tuberculosis Specific HLA-E Restricted CD8(+) T Cells","volume":"48","author":"Prezzemolo","year":"2018","journal-title":"Eur J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445193","article-title":"Human CD8 T Lymphocytes Recognize Mycobacterium Tuberculosis Antigens Presented by HLA-E During Active Tuberculosis and Express Type 2 Cytokines","volume":"45","author":"Caccamo","year":"2015","journal-title":"Eur J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0261OC","article-title":"HLA-E-Restricted CD8(+) T Lymphocytes Efficiently Control Mycobacterium Tuberculosis and HIV-1 Coinfection","volume":"62","author":"La Manna","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500803","article-title":"Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype","volume":"195","author":"Riou","year":"2015","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.06.009","article-title":"Polyfunctional T-Cells and Effector Memory Phenotype Are Associated With Active TB in HIV-Infected Patients","volume":"69","author":"Chiacchio","year":"2014","journal-title":"J Infect"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First Characterization of the CD4 and CD8 T-Cell Responses to QuantiFERON-TB Plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J Infect"},{"key":"B49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical Evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-Tube Assays in Subjects With or Without Tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium Tuberculosis-Specific CD8+ T Cells Are Functionally and Phenotypically Different Between Latent Infection and Active Disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12290","article-title":"Multi-Functional Flow Cytometry Analysis of CD4+ T Cells as an Immune Biomarker for Latent Tuberculosis Status in Patients Treated With Tumour Necrosis Factor (TNF) Antagonists","volume":"176","author":"Sauzullo","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00239","article-title":"Combined Expression of IFN-\u03b3, IL-17, and IL-4 mRNA by Recall PBMCs Moderately Discriminates Active Tuberculosis From Latent Mycobacterium Tuberculosis Infection in Patients With Miscellaneous Inflammatory Underlying Conditions","volume":"7","author":"Savolainen","year":"2016","journal-title":"Front Immunol"},{"key":"B53","unstructured":"What Is QuantiFERON-TB Gold PlusQTF-Plus2021"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00968","article-title":"Analysis of the Phenotype of Mycobacterium Tuberculosis-Specific CD4+ T Cells to Discriminate Latent From Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals","volume":"8","author":"Riou","year":"2017","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02832","article-title":"Atypical Human Effector\/Memory CD4(+) T Cells With a Naive-Like Phenotype","volume":"9","author":"Caccamo","year":"2018","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.10.048","article-title":"Association of Mycobacterial Antigen-Specific CD4(+) Memory T Cell Subsets With Outcome of Pulmonary Tuberculosis","volume":"60","author":"Wang","year":"2010","journal-title":"J Infect"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100090","article-title":"Preferential Infection and Depletion of Mycobacterium Tuberculosis-Specific CD4 T Cells After HIV-1 Infection","volume":"207","author":"Geldmacher","year":"2010","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.9.2767.2767","article-title":"Lymphocyte Subsets and Natural Killer Cell Activity in Healthy Old People and Centenarians","volume":"82","author":"Sansoni","year":"1993","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171358","article-title":"Quantitative and Qualitative Profiles of Circulating Monocytes may Help Identifying Tuberculosis Infection and Disease Stages","volume":"12","author":"La Manna","year":"2017","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202007-2686OC","article-title":"Antigen-Specific T Cell Activation Distinguishes Between Recent and Remote Tuberculosis Infection","volume":"203","author":"Mpande","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"B61","unstructured":"Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.716857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T04:29:17Z","timestamp":1628569757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.716857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2021.716857"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.716857","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"article-number":"716857"}}